James Weidner

Jim Weidner is a seasoned executive with extensive experience in the biotechnology and pharmaceutical industries, currently serving as Vice President of Drug Substance Operations at Amgen. Overseeing a team of over 600 staff, Jim is responsible for ensuring the delivery of drug substance to meet patient needs from multiple facilities. Previous roles at Amgen include Associate Vice President Engineering Technical Authority, where Jim led an international team and spearheaded Amgen's sustainability strategy, and Executive Director of Process Development, where Jim played a crucial role in developing processes for COVID-19 mAb production. Prior to joining Amgen, Jim held senior managerial positions at Biogen Idec and Hoffmann-La Roche, focusing on manufacturing sciences and process engineering. Jim holds an MBA from Lehigh University and a B.S. in Chemical Engineering from North Carolina State University. PI Historian, RT-MVDA, Lab Information Systems).

Jim joined Amgen in 2006 at AML. He led the Process Development Engineering and Purification Sciences groups at Puerto Rico prior to the Singapore assignment in 2013. He has led teams responsible for Process Development, Validation, Engineering, Environmental Sustainability, Automation, Manufacturing and Information Systems at Amgen.

Prior to joining Amgen, he led Manufacturing, Engineering, Process Development and Automation groups at synthetic and biological commercial facilities in the USA.

Jim has a MBA from Lehigh University, and a Bachelor’s degree in Chemical Engineering from North Carolina State University.